BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2406862)

  • 1. Campylobacter pylori: its link to gastritis and peptic ulcer disease.
    Marshall BJ
    Rev Infect Dis; 1990; 12 Suppl 1():S87-93. PubMed ID: 2406862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Campylobacter pylori and therapy with bismuth salts].
    Börsch G
    Med Monatsschr Pharm; 1988 Sep; 11(9):301-7. PubMed ID: 3067064
    [No Abstract]   [Full Text] [Related]  

  • 3. [Campylobacter pylori associated gastritis].
    Internist (Berl); 1989 Dec; 30(12):830-2. PubMed ID: 2621061
    [No Abstract]   [Full Text] [Related]  

  • 4. Campylobacter pylori and its role in peptic ulcer disease.
    Tytgat GN; Rauws EA
    Gastroenterol Clin North Am; 1990 Mar; 19(1):183-96. PubMed ID: 2184128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibacterial treatment of Campylobacter pylori-associated gastritis and peptic ulcer].
    Andreasen JJ; Ringsdal VS
    Ugeskr Laeger; 1989 Apr; 151(17):1030-3. PubMed ID: 2734863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Morphologic change in Campylobacter pylori associated gastritis in and following successful antibacterial therapy].
    Rühl GH; Börsch G
    Pathologe; 1989 Jan; 10(1):64-5. PubMed ID: 2922381
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of antibiotics in Campylobacter pylori associated peptic ulcer disease.
    Bayerdörffer E; Ottenjann R
    Scand J Gastroenterol Suppl; 1988; 142():93-100. PubMed ID: 3047854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Campylobacter pylori-associated antral gastritis in children with bismuth subsalicylate and ampicillin.
    Drumm B; Sherman P; Chiasson D; Karmali M; Cutz E
    J Pediatr; 1988 Nov; 113(5):908-12. PubMed ID: 3183851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Campylobacter pylori: its role in gastritis and peptic ulcer disease.
    Hornick RB
    Curr Clin Top Infect Dis; 1989; 10():157-73. PubMed ID: 2679692
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
    Rösch W
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Electron microscopic findings during treatment of Campylobacter pylori-positive gastritis with bismuth salts].
    Rauws EA; Tytgat GN
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():41-3. PubMed ID: 3687150
    [No Abstract]   [Full Text] [Related]  

  • 12. [What is safe in the treatment of Campylobacter pylori-induced gastritis and Campylobacter pylori-associated peptic ulcer?].
    Menge H
    Internist (Berl); 1988 Nov; 29(11):745-54. PubMed ID: 3069787
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of treatment on Campylobacter pylori in peptic disease: a randomised prospective trial.
    Humphreys H; Bourke S; Dooley C; McKenna D; Power B; Keane CT; Sweeney EC; O'Moráin C
    Gut; 1988 Mar; 29(3):279-83. PubMed ID: 3356357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Campylobacter pylori infection and its relation to chronic gastritis. An endoscopic, bacteriologic, and histomorphologic study.
    Nedenskov-Sørensen P; Bjørneklett A; Fausa O; Bukholm G; Aase S; Jantzen E
    Scand J Gastroenterol; 1988 Sep; 23(7):867-74. PubMed ID: 3067331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bismuth--an environmental pollutant of the future].
    Mueller RL
    Zentralbl Hyg Umweltmed; 1989 Nov; 189(2):117-24. PubMed ID: 2604843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Campylobacter pylori--associated gastritis and peptic ulcer disease in children.
    Kilbridge PM; Dahms BB; Czinn SJ
    Am J Dis Child; 1988 Nov; 142(11):1149-52. PubMed ID: 3177319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Campylobacter pylori-associated gastritis: attempts to eradicate the bacteria by various antibiotics and anti-ulcer regimens.
    Glupczynski Y; Burette A; Nyst JF; De Prez C; De Koster E; Deltenre M
    Acta Gastroenterol Belg; 1988; 51(4-5):329-37. PubMed ID: 2979039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oral bismuth subsalicylate on Campylobacter pylori and on healing and relapse rate of peptic ulcer.
    Eberhardt R; Kasper G
    Rev Infect Dis; 1990; 12 Suppl 1():S115-9. PubMed ID: 2406852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Campylobacter pylori in patients with chronic gastritis and gastric and duodenal peptic ulcer].
    Kolarski V; Tsenova V; Shopova K; Vasileva E; Petrova D
    Vutr Boles; 1989; 28(2):58-62. PubMed ID: 2763525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-line treatment of Helicobacter pylori in Lebanon: Comparison of bismuth-containing quadruple therapy versus 14-days sequential therapy.
    Tarhini M; Fayyad-Kazan M; Fayyad-Kazan H; Mokbel M; Nasreddine M; Badran B; Kchour G
    Microb Pathog; 2018 Apr; 117():23-26. PubMed ID: 29428426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.